Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Teva Pharmaceutical Indus Stock News

TEVANYSE

Logo brought to you by Benzinga Data

Perks Trade with Public

Perks Trade with Public

$16.06

-0.25-1.53%

At close: -

$16.08

0.020.12%

After Hours: 7:37 PM EDT

Q2 2025 Earnings in 11 days from now on Wed Jul 30th, before the market open

Teva Pharmaceutical Indus (TEVA) Forecast

News

Earnings Teva Pharmaceutical Indus (TEVA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Teva Pharmaceutical Indus Stock News | NYSE:TEVA | Benzinga

Get the latest news on Teva Pharmaceutical Indus stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Teva Pharmaceutical Indus performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, July 15, 2025

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights

Thursday, July 10, 2025

Looking Into Teva Pharmaceutical Indus's Recent Short Interest
Benzinga Insights

Thursday, June 26, 2025

FDA Says Manufacture Of Teva Pharmaceuticals'...
Benzinga Newsdesk
What Analysts Are Saying About Teva Pharmaceutical Indus Stock
Benzinga Insights
UBS Maintains Buy on Teva Pharmaceutical Indu...
Benzinga Newsdesk

Monday, June 23, 2025

Teva's Final PEARL Study Data Confirm AJOVY's...
Benzinga Newsdesk

Friday, June 20, 2025

EMA's CHMP Recommended Granting Marketing Aut...
Benzinga Newsdesk

Friday, June 06, 2025

Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?
Vandana Singh
Goldman Sachs Initiates Coverage On Teva Phar...
Benzinga Newsdesk

Thursday, June 05, 2025

How Do Investors Really Feel About Teva Pharmaceutical Indus?
Benzinga Insights

Wednesday, June 04, 2025

9 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights

Monday, June 02, 2025

Reported Friday, Teva Showcases Real-World UZ...
Benzinga Newsdesk

Thursday, May 29, 2025

Teva Reaffirms Growth Strategy, Eyes $5 Billion Innovative Franchise By 2030
Vandana Singh
Teva Provides Updates Ahead Of Its Innovation...
Benzinga Newsdesk

Wednesday, May 28, 2025

Where Teva Pharmaceutical Indus Stands With Analysts
Benzinga Insights
Truist Securities Initiates Coverage On Teva ...
Benzinga Newsdesk

Tuesday, May 27, 2025

Teva Pharmaceutical Industries Announces That...
Benzinga Newsdesk
Why Is Teva Stock Trading Higher On Tuesday?
Vandana Singh
Teva Pharmaceutical Industries shares are tra...
Benzinga Newsdesk
Teva And Biolojic Design Initiate IND-Enablin...
Benzinga Newsdesk

Thursday, May 22, 2025

Teva Pharma Upsizes Debt Tender Offer To $2.2...
Benzinga Newsdesk

Tuesday, May 20, 2025

Teva Pharmaceutical Industries Announces It U...
Benzinga Newsdesk

Monday, May 19, 2025

Teva Launches $2 Billion Bond Buyback to Cut ...
Benzinga Newsdesk

Thursday, May 15, 2025

Teva Pharmaceuticals Announced That Moody's I...
Benzinga Newsdesk

Monday, May 12, 2025

Teva Pharmaceuticals shares are trading highe...
Benzinga Newsdesk
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
This Wayfair Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Avi Kapoor
JP Morgan Upgrades Teva Pharmaceutical Indus ...
Benzinga Newsdesk

Thursday, May 08, 2025

B of A Securities Maintains Buy on Teva Pharm...
Benzinga Newsdesk

Wednesday, May 07, 2025

Teva Shares Climb On Profit Beat, $700 Million Cost Plan, Biopharma Pivot Momentum
Vandana Singh
Teva Pharmaceutical Industries shares are tra...
Benzinga Newsdesk
Teva Pharmaceutical Indus Raises FY2025 Adj E...
Benzinga Newsdesk
Teva Pharmaceutical Indus Q1 Adj. EPS $0.52 B...
Benzinga Newsdesk
Earnings Scheduled For May 7, 2025
Benzinga Insights

Tuesday, May 06, 2025

Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
Vandana Singh

Monday, May 05, 2025

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
Vandana Singh
TEVA stock has given up its prior gain. Teva ...
Benzinga Newsdesk
Market-Moving News for May 5th
Benzinga Newsdesk
Teva Pharmaceuticals shares are trading highe...
Benzinga Newsdesk
Teva Pharma And Alvotech Announce FDA Approva...
Benzinga Newsdesk

Wednesday, April 30, 2025

What Does the Market Think About Teva Pharmaceutical Indus?
Benzinga Insights

Thursday, April 24, 2025

'FDA Commissioner Says 'no Plans' To Pull Abo...
Benzinga Newsdesk

Monday, April 07, 2025

Teva Pharmaceuticals shares are trading highe...
Benzinga Newsdesk
Teva And Samsung Bioepis Announce Biosimilar ...
Benzinga Newsdesk
Teva Announces FDA Filing Acceptance For AJOV...
Benzinga Newsdesk

Monday, March 31, 2025

Teva Highlights Phase 3 SOLARIS Trial Survey ...
Benzinga Newsdesk

Thursday, March 27, 2025

Teva Pharmaceutical Sees Q1 EPS $0.52 Vs $0.5...
Benzinga Newsdesk
Teva Pharmaceutical Sees FY25 EPS $2.35-$2.65...
Benzinga Newsdesk
Teva Pharmaceutical Indus Unusual Options Activity
Benzinga Insights

Friday, March 21, 2025

Teva Pharmaceutical Indus's Options: A Look at What the Big Money is Thinking
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved